323 related articles for article (PubMed ID: 11585048)
1. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
Bisogno T; De Petrocellis L; Di Marzo V
Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157
[TBL] [Abstract][Full Text] [Related]
3. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
[TBL] [Abstract][Full Text] [Related]
6. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
Fowler CJ; Jacobsson SO
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Vázquez C; Tolón RM; Pazos MR; Moreno M; Koester EC; Cravatt BF; Hillard CJ; Romero J
Neurobiol Dis; 2015 Jul; 79():41-50. PubMed ID: 25917763
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
10. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
11. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
Zimmermann T; Bartsch JC; Beer A; Lomazzo E; Guggenhuber S; Lange MD; Bindila L; Pape HC; Lutz B
Neuropsychopharmacology; 2019 Jul; 44(8):1377-1388. PubMed ID: 30532004
[TBL] [Abstract][Full Text] [Related]
12. The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.
Griebel G; Stemmelin J; Lopez-Grancha M; Fauchey V; Slowinski F; Pichat P; Dargazanli G; Abouabdellah A; Cohen C; Bergis OE
Sci Rep; 2018 Feb; 8(1):2416. PubMed ID: 29403000
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
Tiger G; Stenström A; Fowler CJ
Biochem Pharmacol; 2000 Mar; 59(6):647-53. PubMed ID: 10677581
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
15. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
16. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
17. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
Boger DL; Sato H; Lerner AE; Hedrick MP; Fecik RA; Miyauchi H; Wilkie GD; Austin BJ; Patricelli MP; Cravatt BF
Proc Natl Acad Sci U S A; 2000 May; 97(10):5044-9. PubMed ID: 10805767
[TBL] [Abstract][Full Text] [Related]
18. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
19. Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade.
Maccarrone M; Salvati S; Bari M; Finazzi-Agró
Biochem Biophys Res Commun; 2000 Nov; 278(3):576-83. PubMed ID: 11095952
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]